MRKR Marker Therapeutics Inc
Company Analysis
Latest News
🟢 Marker Therapeutics is trading 7% up — no clear catalyst identified
Marker Therapeutics is trading 7.03% up at $0.97, with no clear company-specific catalyst identified for October 27, 2026. - The latest company news located...
🔴 Marker Therapeutics is trading 6.3% down
Marker Therapeutics is trading 6.3% lower at $0.90 on October 26, 2026, with no company-specific announcement or clear catalyst identified for the decline. -...
🔴 Marker Therapeutics is trading 7% down on October 23 amid broader biotech weakness
Marker Therapeutics is trading at $0.99, down 7.01%; sector pressure offers context, but the cause of the larger decline remains uncertain. - No...
🟢 Marker Therapeutics is trading 14.93% up in pre-market with no identified new company-specific catalyst
Marker Therapeutics is trading 14.93% higher in pre-market at $1.23, compared with its October 22 close of $1.07. No new company-specific announcement dated...
🟢 Marker Therapeutics is trading 6% up today as biotech sector rises; link unconfirmed
Marker Therapeutics is trading at $1.23, up +6.03%, with biotech-sector strength the clearest available support for the move; a direct link is unconfirmed. -...
🔴 Marker Therapeutics is trading 5% down — cause remains unclear
Marker Therapeutics is trading at $1.14, down 5.00%, with the reason for the October 20 decline unclear. - On October 19, Marker Therapeutics announced a $2.6...
🔴 Marker Therapeutics is trading 16.64% down in pre-market amid biotech-sector weakness
Marker Therapeutics is trading 16.64% lower in pre-market at $1.00 on October 20, 2026, amid biotech-sector weakness; no clear company-specific negative...
🔴 Marker Therapeutics is trading 5% down in after-hours trading
Marker Therapeutics is trading at $1.14, down 5.00%, in after-hours trading; the available information does not establish a reason for the decline. - It...
🟢 Marker Therapeutics is trading 11.06% up today after announcing a $2.6 million FDA grant
Marker Therapeutics is trading at $1.16, up 11.06%, after announcing a $2.6 million FDA grant. - On October 19, the company announced the non-dilutive funding...
FDA Grant Gives Marker Therapeutics a Lifeline for Its Pancreatic Cancer Bet, but Can $2.6 Million Move the Needle for a $1 Stock?
Shares of Marker Therapeutics surged as much as 7.5% to $1.12 on October 19 after the company disclosed that the FDA awarded it a $2.6 million grant to fund a...
🟢 Marker Therapeutics is trading 7.5% up today after a $2.6 million FDA grant for MT-601
Marker Therapeutics is trading at $1.12, up 7.50% on October 19, 2026, after receiving a $2.6 million FDA grant for its MT-601 Phase 1 study. - The...
Marker Therapeutics Awarded $2.6M FDA Grant to Advance Pancreatic Cancer Therapy
Marker Therapeutics announced it has been awarded a $2.6 million grant from the U.S. Food and Drug Administration (FDA) under its Orphan Products development...
🟢 Marker Therapeutics is trading at 5.8% up in pre-market with no clear catalyst
Marker Therapeutics is trading 5.8% higher at $1.10 in pre-market, with the immediate catalyst unclear. - Shares extended the October 16 advance, closing at...
🟢 Marker Therapeutics is trading 5.8% up in after-hours trading
Marker Therapeutics is trading at $1.10, up 5.77% after hours, with the catalyst unclear. - It rose 13.04% in the regular session on October 16, closing at...
🟢 Marker Therapeutics is trading 14.13% up today amid a biotech sector rally
Marker Therapeutics is trading at $1.05, up 14.13%, amid a biotech sector rally. - The XBI was up 2.20% in regular trading, supporting a sector explanation...
🟢 Marker Therapeutics is trading 7.8% up in pre-market
Marker Therapeutics is trading at $0.99, up 7.77% in pre-market, with no clear company-specific catalyst identified. - The gain follows a 3.35% rise at the...
🟢 Marker Therapeutics is trading 6.4% up in after-hours trading — no clear catalyst identified
Marker Therapeutics is trading at $0.98, up +6.41%, and available evidence does not establish a specific reason for its October 15 after-hours move. - The...
🟢 Marker Therapeutics is trading 7.5% up on October 15, 2026 — no clear company-specific catalyst identified
Marker Therapeutics is trading at $0.96, up 7.52%, with no clear company-specific catalyst identified. - Marker Therapeutics’ investor-relations page lists...
🔴 Marker Therapeutics is trading 5.9% down today amid biotech-sector weakness
Marker Therapeutics is trading 5.89% lower at $0.95, in line with biotech-sector weakness; no company-specific catalyst was identified. - No new...
🟢 Marker Therapeutics is trading 6% up; no catalyst identified
Marker Therapeutics is trading at $1.03, up 6.01%, with the gain unexplained. - No October 12 company-specific catalyst was identified; the investor-relations...